IAS 2023
Oral Bridging of Lenacapavir Maintains Viral Suppression Among HIV Patients
Oral bridging of lenacapavir enabled patients to maintain viral suppression of their HIV after missed doses of ...
JULY 26, 2023
Mortality Risk During Omicron Wave Saw Modest Decrease in Death for HIV Patients
Although the risk for death during the omicron wave of COVID-19 fell dramatically for people without HIV, the risk ...
JULY 26, 2023
Cisgender Women in 7 African Countries Prefer Long-Acting Cabotegravir PrEP
Nearly eight out of 10 cisgender women preferred long-acting injectable cabotegravir to daily oral pre-exposure ...
JULY 26, 2023
Geneva Patient Still in HIV Remission 20 Months After HSCT
A man who was diagnosed with HIV decades ago has been in HIV remission for 20 months without antiretroviral therapy ...
JULY 24, 2023
Australia May Be First Nation to End HIV
New evidence suggest that Australia may become world’s first nation to end HIV epidemic.
JULY 24, 2023
Sometimes Even ‘Detectable’ Can Mean Untransmissible
People living with HIV who maintain low—but still detectible—levels of the virus but adhere to their ...
JULY 24, 2023
